✦ LIBER ✦

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

✍ Scribed by Daniel R Murphy, Lee J Smolen, Timothy M Klein, Robert W Klein

Book ID: 119898882
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 693 KB
Volume: 13
Category: Article
ISSN: 1471-2474
DOI: 10.1186/1471-2474-13-213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS35 COST-EFFECTIVENESS OF TERIPARATIDE

PMS35 COST-EFFECTIVENESS OF TERIPARATIDE IN PATIENTS WITH GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN SWEDEN

✍ LJ Smolen; Z Gregor; A Barrett; KJ Myrén; A Toll 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

A Cost-Effectiveness Model of Tibolone a

A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

✍ Michael Willis, Knut Ödegaard, Ulf Persson, Johan Hedbrant, Dan Mellström, Mats 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 229 KB

Cost-effectiveness of risedronate for th

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women

✍ J. A. Kanis; F. Borgstrom; O. Johnell; B. Jonsson 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 235 KB

PMS40 Cost-Effectiveness of Denosumab fo

PMS40 Cost-Effectiveness of Denosumab for the Treatment of Male Osteoporosis (MOP) in the Elderly in Sweden

✍ A. Parthan; M.M. Deflin; I. Agodoa; C.Y. Tao; S.L. Silverman; E. Orwoll 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Pharmacoeconomic profile of paclitaxel a

Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma : A lifetime cost-effectiveness analysis

✍ Andrea Messori; Michele Cecchi; Paola Becagli; Sabrina Trippoli 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

medullary recurrence in certain ethnic groups will be the field have read the article. I agree that there is no proof that all-trans retinoic acid (ATRA) therapy confirmed by further observation and analysis of recurrence in the large cooperative group studying APL. predisposes patients to the deve

PCN90 Cost Effectiveness Analysis of Ben

PCN90 Cost Effectiveness Analysis of Bendamustine as First Line Treatment for Chronic Lymphocytic Leukaemia in the Netherlands

✍ S. Vandekerckhove; K. Holtzer-Goor; D. Van Den Steen; Y. van Megen; P. Huijgens; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB